propranolol accord 10 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - propranolol hydrochloride - tabletti, kalvopäällysteinen - 10 mg - propranololi
propranolol accord 40 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - propranolol hydrochloride - tabletti, kalvopäällysteinen - 40 mg - propranololi
propranolol accord 80 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - propranolol hydrochloride - tabletti, kalvopäällysteinen - 80 mg - propranololi
atovaquone/proguanil glenmark 250 mg / 100 mg tabletti, kalvopäällysteinen
glenmark arzneimittel gmbh - proguanili hydrochloridum,atovaquonum - tabletti, kalvopäällysteinen - 250 mg / 100 mg - proguaniili, yhdistelmävalmisteet
ranoprin 40 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - propranolol hydrochloride - tabletti, kalvopäällysteinen - 40 mg - propranololi
ranoprin 80 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - propranolol hydrochloride - tabletti, kalvopäällysteinen - 80 mg - propranololi
propral 10 mg tabletti
orion corporation - propranolol hydrochloride - tabletti - 10 mg - propranololi
propral 40 mg tabletti
orion corporation - propranolol hydrochloride - tabletti - 40 mg - propranololi
atovaquone/proguanil ratiopharm 250 mg / 100 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - atovaquonum,proguanili hydrochloridum - tabletti, kalvopäällysteinen - 250 mg / 100 mg - proguaniili, yhdistelmävalmisteet
hemangiol
pierre fabre medicament - propranololihydrokloridia - hemangioma - beeta-estäjät - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.